[Surgical treatment of Mycobacterium avium complex lung disease].
Mycobacterium avium complex (MAC) lung disease is the most common nontuberculous mycobacterial lung disease in Japan and is difficult to treat. Multidrug regimen employing clarithromycin, rifampicin, and ethambutol is not a panacea. Pulmonary resection may be beneficial to patients whose disease is predominantly localized to one lung and who can tolerate resectional surgery under the following circumstances: poor response to drug therapy, the development of macrolide-resistant MAC disease, or the presence of hemoptysis. Resectional surgery for MAC lung disease can achieve favorable treatment outcome. However, this type of surgery is associated with a relatively high morbidity and should be performed by experienced hands.